Home
ATRA
ATRA News

Latest Atara Biotherapeutics Inc. (ATRA) News on December 23, 2024

MT Newswires

3 days ago

Rodman & Renshaw Initiates Coverage on Atara Biotherapeutics With Buy Rating, $25 Price Target

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

GlobeNewswire

19 days ago

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference

Business Wire

25 days ago

Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference

Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a month ago

Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference

Business Wire

a month ago

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference

Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a month ago

Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

a month ago

Atara Biotherapeutics: Q3 Earnings Snapshot

Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress

Business Wire

a month ago

Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Business Wire

2 months ago

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know

Zacks

2 months ago

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GuruFocus.com

3 months ago

Redmile Group, LLC Expands Stake in Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire

4 months ago

Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

MT Newswires

4 months ago

Top Midday Gainers

MT Newswires

4 months ago

Atara Biotherapeutics to Raise $36 Million From Direct Offering; Shares Soar After-Hours

Atara Biotherapeutics Announces $36 Million Registered Direct Offering

Business Wire

4 months ago

Atara Biotherapeutics Announces $36 Million Registered Direct Offering

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Just Reported Earnings, And Analysts Cut Their Target Price

Simply Wall St.

4 months ago

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Just Reported Earnings, And Analysts Cut Their Target Price

Atara Biotherapeutics Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

4 months ago

Atara Biotherapeutics Second Quarter 2024 Earnings: Misses Expectations

Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates

Zacks

4 months ago

Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates

Associated Press Finance

4 months ago

Atara Biotherapeutics: Q2 Earnings Snapshot

Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update

Business Wire

4 months ago

Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update

Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

Business Wire

4 months ago

Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

US FDA grants priority review for Pierre Fabre’s EBV+ PTLD

Pharmaceutical Technology

5 months ago

US FDA grants priority review for Pierre Fabre’s EBV+ PTLD

FDA priority review advances Atara’s tabelecleucel for viral infection

Pharmaceutical Technology

5 months ago

FDA priority review advances Atara’s tabelecleucel for viral infection

MT Newswires

5 months ago

Atara Biotherapeutics Says Tab-Cel Biologics License Application Gets FDA Priority Review

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Business Wire

5 months ago

Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy

Zacks

5 months ago

All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum

Business Wire

6 months ago

Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum

Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases

Business Wire

6 months ago

Atara Biotherapeutics’ Ebvallo™ (tabelecleucel) Wins Prix Galien International Award for Best Product for Orphan/Rare Diseases

Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split

Business Wire

6 months ago

Atara Biotherapeutics Announces 1-for-25 Reverse Stock Split

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Business Wire

7 months ago

Atara Biotherapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting

Business Wire

7 months ago

Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting

Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

Zacks

7 months ago

Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals

Zacks

7 months ago

GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals

MT Newswires

7 months ago

Atara Biotherapeutics Files Biologics License Application for Tabelecleucel with FDA; Shares Rise

Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA

Business Wire

7 months ago

Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA

Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

7 months ago

Atara Biotherapeutics First Quarter 2024 Earnings: Beats Expectations

Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates

Zacks

7 months ago

Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

7 months ago

Atara Biotherapeutics: Q1 Earnings Snapshot

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress

Business Wire

7 months ago

Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates

Zacks

9 months ago

Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

9 months ago

Atara Biotherapeutics: Q4 Earnings Snapshot

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Business Wire

9 months ago

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy

Business Wire

10 months ago

Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference

Business Wire

10 months ago

Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 44th Annual Health Care Conference

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis

Business Wire

10 months ago

Atara Biotherapeutics Announces Submission of Investigational New Drug Application for ATA3219 for Treatment of Lupus Nephritis

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain

Simply Wall St.

a year ago

After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners must be relieved by the recent gain

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Business Wire

a year ago

Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

PR Newswire

a year ago

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

PR Newswire

a year ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

GlobeNewswire

a year ago

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

Business Wire

a year ago

AMTD Digital’s Entertainment and Movie Businesses Are Estimated to Contribute Significantly to Net Profit

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

Business Wire

a year ago

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

Business Wire

a year ago

AMTD Digital’s Half Yearly Net Profit is Estimated to Increase over 150% Year over Year

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

Investor's Business Daily

a year ago

Charles Schwab Boosts Its Online Brokerage With Big TD Ameritrade Deal

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

PR Newswire

a year ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Canoo: Buy, Sell, or Hold?

Motley Fool

a year ago

Canoo: Buy, Sell, or Hold?

Schwab Earnings Beat Estimates. Why the Stock Is Dropping.

Barrons.com

a year ago

Schwab Earnings Beat Estimates. Why the Stock Is Dropping.

Canoo Delivered Electric Vehicles to Kingbee

GlobeNewswire

a year ago

Canoo Delivered Electric Vehicles to Kingbee

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments

ACCESSWIRE

a year ago

Loop Industries Reports Third Quarter Fiscal 2024 Results and Provides Updates on Business Developments

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution

Business Wire

a year ago

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Quarterly Distribution

Lavoro to Announce Fiscal First Quarter 2024 Results on January 24th, 2024

GlobeNewswire

a year ago

Lavoro to Announce Fiscal First Quarter 2024 Results on January 24th, 2024

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers

Business Wire

a year ago

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers

ARIS MINING ACHIEVES 2023 PRODUCTION GUIDANCE AND PROVIDES 2024 OUTLOOK

PR Newswire

a year ago

ARIS MINING ACHIEVES 2023 PRODUCTION GUIDANCE AND PROVIDES 2024 OUTLOOK

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

Zacks

a year ago

EV Roundup: TSLA's Berlin Output Halt & HMC's New EV Series Hog the Limelight

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'

Zacks

a year ago

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors

Business Wire

a year ago

Vast Announces Appointment of Two Additional Directors to its Recently Expanded Board of Directors

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

GuruFocus.com

a year ago

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Seth Klarman's Exit from Atara Biotherapeutics Inc

GuruFocus.com

a year ago

Seth Klarman's Exit from Atara Biotherapeutics Inc

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

CNW Group

a year ago

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

VirTra, Inc. (VTSI) Hits Fresh High: Is There Still Room to Run?

Zacks

a year ago

VirTra, Inc. (VTSI) Hits Fresh High: Is There Still Room to Run?

Atara Biotherapeutics Announces $15 Million Registered Direct Offering

Business Wire

a year ago

Atara Biotherapeutics Announces $15 Million Registered Direct Offering

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024

Business Wire

a year ago

Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2024

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Atara Biotherapeutics to Present Recent Progress and Key Upcoming Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term

Simply Wall St.

a year ago

Loss-Making Beam Global (NASDAQ:BEEM) Expected To Breakeven In The Medium-Term

AMTD IDEA Awarded "Best Financial Services" Recognition

Business Wire

a year ago

AMTD IDEA Awarded "Best Financial Services" Recognition

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Atara Biotherapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services

GlobeNewswire

a year ago

ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

PR Newswire

a year ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

3 Communication Stocks Likely to Sail Against Industry Odds

Zacks

a year ago

3 Communication Stocks Likely to Sail Against Industry Odds

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

PR Newswire

a year ago

Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right

Estimating The Fair Value Of Niu Technologies (NASDAQ:NIU)

Simply Wall St.

a year ago

Estimating The Fair Value Of Niu Technologies (NASDAQ:NIU)

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

Business Wire

a year ago

Atara Biotherapeutics Announces Closing of Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories

Nature’s Sunshine Recognized with Best Company Culture Award

GlobeNewswire

a year ago

Nature’s Sunshine Recognized with Best Company Culture Award

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions

Business Wire

a year ago

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Declare Quarterly Distributions

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications

ACCESSWIRE

a year ago

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

GlobeNewswire

a year ago

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

New Strong Buy Stocks for December 11th

Zacks

a year ago

New Strong Buy Stocks for December 11th

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?

Simply Wall St.

a year ago

Does The Market Have A Low Tolerance For DHI Group, Inc.'s (NYSE:DHX) Mixed Fundamentals?

Share on Social Networks: